No Cognitive Benefit from Heart Drugs in HOPE-3

ACC Conference Reporter

AHA 2016 | NEW ORLEANS — A large substudy of the HOPE-3 trial found no benefit relating to cognitive function in patients who took cholesterol or blood pressure-lowering drugs. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA16


< Back to Listings